Autopsy report · NCT03844568

Nocturnal Nasal Continuous Positive Airway Pressure in Aspiration Pneumonia

“Hard to recruit due to COVID-19 issue.”

The sponsor’s own words in the registry.

Life of this trial

• Withdrawn before it enrolled anyone. Its dates are the sponsor's plans, not events that happened.

Vital statistics

Status

Withdrawn

Phase

Na

Sponsor

Seoul National University Hospital

Sponsor type

University, hospital or other

Conditions

Aspiration Pneumonia

Interventions

nocturnal nasal continuous positive airway pressure

Participants

0

Sites

1

Countries

South Korea

Trials that died the same way

• (mo)BETTA Trial in Transwomen for Optimization of ART
  “Lack of ability to recruit due to COVID-19 pandemic” (88% match in meaning)
• Prospective Study on DEXTENZA® Safety And Efficacy Following Concomitant MIGS and Cataract Surgery
  “COVID-19 challenges to recruitment” (87% match in meaning)
• Compression Wraps as Adjuvant Therapy in Management of Acute Systolic Heart Failure
  “challenges in recruitment due to covid-19” (87% match in meaning)
• Effect of Dupilumab on Sleep Apnea in Patients With Rhinosinusitis
  “Inability to recruit during COVID” (85% match in meaning)
• Acute Effects of the Prostaglandin (Alprostadil) on Cerebral and Pulmonary Flow
  “Covid 19 and difficulty with recruitment” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.